Raymond J. Henley Iii

Array ( [id] => 6886754 [patent_doc_number] => 20010020023 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-09-06 [patent_title] => 'Pharmaceutical compositions for the treatment of rhinitis' [patent_app_type] => new [patent_app_number] => 09/838190 [patent_app_country] => US [patent_app_date] => 2001-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4321 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20010020023.pdf [firstpage_image] =>[orig_patent_app_number] => 09838190 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1024834 [patent_doc_number] => 06884794 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-04-26 [patent_title] => 'Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets' [patent_app_type] => utility [patent_app_number] => 10/257368 [patent_app_country] => US [patent_app_date] => 2001-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9148 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 155 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/884/06884794.pdf [firstpage_image] =>[orig_patent_app_number] => 10257368 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5889353 [patent_doc_number] => 20020013370 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-31 [patent_title] => 'Methods for identifying and treating resistant tumors' [patent_app_type] => new [patent_app_number] => 09/836567 [patent_app_country] => US [patent_app_date] => 2001-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 19704 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20020013370.pdf [firstpage_image] =>[orig_patent_app_number] => 09836567 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5951916 [patent_doc_number] => 20020006926 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-17 [patent_title] => 'Use of cyclic GMP-specific phosphodiesterase inhibitors for treatment of parkinson\'s disease' [patent_app_type] => new [patent_app_number] => 09/836744 [patent_app_country] => US [patent_app_date] => 2001-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5920 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0006/20020006926.pdf [firstpage_image] =>[orig_patent_app_number] => 09836744 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1514749 [patent_doc_number] => 06420351 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-16 [patent_title] => 'Methods for treating neuropsychiatric disorders' [patent_app_type] => B1 [patent_app_number] => 09/834351 [patent_app_country] => US [patent_app_date] => 2001-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5043 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/420/06420351.pdf [firstpage_image] =>[orig_patent_app_number] => 09834351 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1533423 [patent_doc_number] => 06410601 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-25 [patent_title] => 'Histochrome and its therapeutic use in acute myocardial infarction and ischemic heart disease' [patent_app_type] => B1 [patent_app_number] => 09/832864 [patent_app_country] => US [patent_app_date] => 2001-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3133 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/410/06410601.pdf [firstpage_image] =>[orig_patent_app_number] => 09832864 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6033571 [patent_doc_number] => 20020019407 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-14 [patent_title] => 'Methylxanthines in the diagnosis and treatment of autistic disorder' [patent_app_type] => new [patent_app_number] => 09/834169 [patent_app_country] => US [patent_app_date] => 2001-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5515 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20020019407.pdf [firstpage_image] =>[orig_patent_app_number] => 09834169 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1554008 [patent_doc_number] => 06348502 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-19 [patent_title] => 'Formulations for the treatment of gastro-oesophageal reflux' [patent_app_type] => B1 [patent_app_number] => 09/719129 [patent_app_country] => US [patent_app_date] => 2001-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3661 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/348/06348502.pdf [firstpage_image] =>[orig_patent_app_number] => 09719129 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1553962 [patent_doc_number] => 06348488 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-19 [patent_title] => 'Remedies for motor dysfunction and GAPDH expression inhibitors' [patent_app_type] => B1 [patent_app_number] => 09/806572 [patent_app_country] => US [patent_app_date] => 2001-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 4341 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/348/06348488.pdf [firstpage_image] =>[orig_patent_app_number] => 09806572 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1416828 [patent_doc_number] => 06521647 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-02-18 [patent_title] => 'Treatment of renal disorders' [patent_app_type] => B2 [patent_app_number] => 09/818403 [patent_app_country] => US [patent_app_date] => 2001-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3951 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/521/06521647.pdf [firstpage_image] =>[orig_patent_app_number] => 09818403 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1596357 [patent_doc_number] => 06492375 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-12-10 [patent_title] => 'Partially saturated calcium channel blockers' [patent_app_type] => B2 [patent_app_number] => 09/818063 [patent_app_country] => US [patent_app_date] => 2001-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6918 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 262 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/492/06492375.pdf [firstpage_image] =>[orig_patent_app_number] => 09818063 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1533380 [patent_doc_number] => 06410589 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-25 [patent_title] => 'Use of -tocopherol and its oxidative metabolite LLU- in the treatment of disease' [patent_app_type] => B1 [patent_app_number] => 09/814330 [patent_app_country] => US [patent_app_date] => 2001-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14242 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/410/06410589.pdf [firstpage_image] =>[orig_patent_app_number] => 09814330 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1507731 [patent_doc_number] => 06440930 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-27 [patent_title] => 'Protein formulations' [patent_app_type] => B1 [patent_app_number] => 09/787500 [patent_app_country] => US [patent_app_date] => 2001-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5893 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/440/06440930.pdf [firstpage_image] =>[orig_patent_app_number] => 09787500 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 979092 [patent_doc_number] => 06930096 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-08-16 [patent_title] => 'Use of CDP-choline for the prophylactic treatment of cerebral ischemia' [patent_app_type] => utility [patent_app_number] => 10/221581 [patent_app_country] => US [patent_app_date] => 2001-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 2338 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/930/06930096.pdf [firstpage_image] =>[orig_patent_app_number] => 10221581 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6892286 [patent_doc_number] => 20010018448 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-08-30 [patent_title] => 'Medicament' [patent_app_type] => new [patent_app_number] => 09/805474 [patent_app_country] => US [patent_app_date] => 2001-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11805 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20010018448.pdf [firstpage_image] =>[orig_patent_app_number] => 09805474 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6062983 [patent_doc_number] => 20020031561 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-14 [patent_title] => 'Chemical composition for aiding the absorption, binding and elimination of undigested fat' [patent_app_type] => new [patent_app_number] => 09/808646 [patent_app_country] => US [patent_app_date] => 2001-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3637 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20020031561.pdf [firstpage_image] =>[orig_patent_app_number] => 09808646 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7028853 [patent_doc_number] => 20010014698 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-08-16 [patent_title] => 'Method for preventing and treating alcoholism' [patent_app_type] => new [patent_app_number] => 09/804742 [patent_app_country] => US [patent_app_date] => 2001-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8007 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20010014698.pdf [firstpage_image] =>[orig_patent_app_number] => 09804742 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1485766 [patent_doc_number] => 06365622 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-02 [patent_title] => 'Antioxidant composition comprising acetyl L-carnitine and -lipoic acid' [patent_app_type] => B1 [patent_app_number] => 09/786153 [patent_app_country] => US [patent_app_date] => 2001-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5257 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/365/06365622.pdf [firstpage_image] =>[orig_patent_app_number] => 09786153 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1601963 [patent_doc_number] => 06432398 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-13 [patent_title] => 'Methods of treating diseased cells' [patent_app_type] => B1 [patent_app_number] => 09/786872 [patent_app_country] => US [patent_app_date] => 2001-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7079 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/432/06432398.pdf [firstpage_image] =>[orig_patent_app_number] => 09786872 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6048771 [patent_doc_number] => 20020169212 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-14 [patent_title] => 'Ketoprofen powder for oral use' [patent_app_type] => new [patent_app_number] => 09/801908 [patent_app_country] => US [patent_app_date] => 2001-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2183 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20020169212.pdf [firstpage_image] =>[orig_patent_app_number] => 09801908 [rel_patent_id] =>[rel_patent_doc_number] =>)